Creation of JV Co with Nan Fund Group for commercialisation announced by Celltrion

Jul 18, 2019

Celltrion announces creation of JV Co with Nan Fung Group for the commercialisation of Remsima®, Truxima® and Herzuma® in China. The joint venture company, Vcell Healthcare will obtain exclusive rights to develop, manufacture and commercialise these three products in mainland China.

Print Page Mail Article